RANK产品信息
别称:RANK,TNFRSF11A,CD265
物种:Human
属性:Protein/Cell
标记:Unconjugated
内毒素(Endotoxin)
Less than 0.1 EU per μg by the LAL method.
纯度(Purity)
>95% as determined by SDS-PAGE.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
RANK用户评价
RANK分子背景
RANK/TNFRSF11A是肿瘤坏死因子受体家族的成员。RANK/TNFRSF11A在其细胞外四个富含半胱氨酸的重复序列中与TNFR家族的其他成员具有显著的氨基酸同源性。小鼠的功能基因组学表明,RANKL(TNFSF11)是TNF配体超家族的成员,RANK(TNFRSF11a)是RANKL的同源TNFR家族受体,对体内破骨细胞生成至关重要。由成骨细胞谱系的骨基质细胞表达的RANKL和由造血髓系谱系的破骨细胞前体表达的RANK之间的功能相互作用是破骨细胞分化、存活和激活所必需的。
关键字: RANK;RANK蛋白;RANK重组蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。